Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

in clinical trials were fatigue/asthenia (65%), headache (43%), pyrexia (41%), myalgia (40%), irritability/anxiety/nervousness (33%), insomnia (30%), alopecia (28%), neutropenia (27%), nausea/vomiting (25%), rigors (25%), anorexia (24%), injection site reaction (23%), arthralgia (22%), depression (20%), pruritus (19%) and dermatitis (16%).

Serious adverse events in hepatitis C trials included neuropsychiatric disorders (homicidal ideation, suicidal ideation, suicide attempt, suicide, psychotic disorder and hallucinations), serious and severe bacterial infections (sepsis), bone marrow toxicity (cytopenia and rarely, aplastic anemia), cardiovascular disorders (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages, optic neuritis and papilledema). Adverse reactions reported during post-approval use of PEGASYS therapy, with and without ribavirin, include hearing impairment, hearing loss, serious skin reactions, including erythema multiforme major, and infections (bacterial, viral and fungal).

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that ad
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Decision ... changes brought about by the Affordable Care ... and prescribing of pharmaceutical therapies. The ACA ... beneficiaries through new regulations and expanded access ... in the health exchanges—state-based marketplaces set up ...
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
(Date:7/31/2014)... -- Lazarus Effect, a medical device company focused on ... of blood clots, announced the closing of a $5 ... commercialization of several approved Lazarus Effect devices, as well ... Cover™ in the United States . ... value of our novel, platform technology as well as ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2
... 14, 2011 OCuSOFT, Inc., an ophthalmic pharmaceutical research, ... agreement with Ardeo Health, LLC to distribute a novel ... of Evry, France, Nova23041. Nova23041 will be ... as Retaine® MGD™ Ophthalmic Emulsion under a brand license ...
... Better Health ™, a program of Lilly USA, LLC, ... healthier, more active lives, launches an enhanced multi-channel platform ... health information. The platform includes an array of patient ... manage their health, a dynamic website – lillyforbetterhealth.com ...
Cached Medicine Technology:Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 2Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 3Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 2Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 3
(Date:8/1/2014)... (August 1, 2014)The use of electronic reminders such as ... getting surgical patients to adhere to a preadmission antiseptic ... site infections (SSIs), according to a first-of-its-kind study published ... the American College of Surgeons . , Each year ... rate approaching nearly 100,000 according to data sources cited ...
(Date:8/1/2014)... 2014 Chilton Medical Center has ... to empower patients and their families to take ... by providing easy, secure access to their medical ... web-based access to their health information at Chilton ... allergies, demographic information, visit history, discharge/aftercare information, and ...
(Date:8/1/2014)... 01, 2014 Ticket Down is a reputable ... Lane Farms in Knoxville/Greenback, TN; Ingram Farms in Auburn/Opelika, AL; ... in Archer/Gainesville, FL. Luke Bryan is currently out on his ... and Cole Swindell. Bryan is responsible for one of the ... and this year, just because the summer is over doesn’t ...
(Date:8/1/2014)... 2014 With fast food restaurants on almost ... of processed, microwavable dinners, it is no wonder that America ... patients a mere quick fix for shedding this dangerous excess ... of the country, get slimmer and healthier for the long ... tools and education on how to avoid obesity , ...
(Date:8/1/2014)... A new study published in ... contribute to the development of colorectal cancer in patients ... study was authored by Alberto Martin of the University ... intestinal cells to multiply and create tumors in mice ... , “What’s interesting about this study,” said Shahab Mehdizadeh, ...
Breaking Medicine News(10 mins):Health News:Electronic reminders can help patients prevent surgical site infections 2Health News:Electronic reminders can help patients prevent surgical site infections 3Health News:Chilton Medical Center Launches Online Patient Portal 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3Health News:Carbs May Contribute to Colon Cancer 2
... OCTOBER 15, 2007 -- The Cardiovascular Research ... research study, HORIZONS AMI (Harmonizing Outcomes with Revascularization ... nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium ... examine the safety and effectiveness of stents and ...
... decline over past decade , , MONDAY, Oct. 15 (HealthDay News) ... the United States, offering what an expert called a "glimmer ... new report, cancer death rates fell by 2.1 percent each ... percent annual decline recorded between 1993 and 2003. , "That,s ...
... 2007 New research presented at the 72nd ... Gastroenterology emphasizes the importance of colorectal cancer (CRC) ... a higher incidence of colorectal cancer compared to ... advanced polyps on the right side of the ...
... 2007 Using a model to predict reductions ... researchers from Memorial Sloan-Kettering looked at the relative ... pre-cancerous polyps from the colon versus surveillance follow-up ... Winawer, M.D., MACG and colleagues presented their findings ...
... A new analysis of randomized controlled trials ... syndrome (IBS) has found that Bifantis, Bifidobacterium infantis ... Procter & Gamble), is the only probiotic currently ... based upon a properly designed research study. Researchers ...
... 15 Level I and II,Trauma Center accreditation status has ... 15, 2007 through,September 30, 2008: Regional Resource Trauma Center ... Hospital Johnstown -- Conemaugh Memorial Medical ... Center Philadelphia -- Hahnemann University Hospital ...
Cached Medicine News:Health News:Horizons AMI trial data to be presented at TCT 2007 2Health News:U.S. Cancer Death Rate Continues to Fall 2Health News:U.S. Cancer Death Rate Continues to Fall 3Health News:Racial and ethnic differences in colorectal cancer emphasize importance of screening 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 3Health News:Review of probiotic research finds only Bifantis can claim efficacy vs. placebo for IBS symptoms 2Health News:Pennsylvania Trauma Center Accreditation Status 2
Idophor PVP Scrub Winged Sponges...
... E*Kits® can be a valuable tool in ... the items necessary for a procedure are ... and continuum of care are easier to ... in sequence of use, allowing the clinician ...
Triad Plus PVP-I Scrub Winged Sponges...
... wet trays to dry trays to specialty ... trays, Cardinal Health offers the widest offering ... contain components that are proven to be ... risk of surgical site infections. Cardinal Health ...
Medicine Products: